Derek is an Infectious Diseases consultant and senior lecturer with the University of St Andrews with a long-standing interest in the clinical management of tuberculosis.
Much of his research has been affiliated to or conducted in close collaboration with, LSTM. His work focusses on the clinical pharmacology of anti-tuberculous drugs, evaluation of novel biomarkers to monitor treatment response in patients, and clinical trials of new treatment regimens.
This seminar will outline the background to his interest in TB therapeutics, provide an overview of his work to date, and outline some evolving ideas which may contain scope for future collaborations.
Dr Sloan has spent many years working in the management of infectious diseases, particularly tuberculosis (TB). He has contributed to patient care and TB Control Programmes in Kenya, South Africa, Malawi, England and Scotland.
He completed a Wellcome Trust PhD fellowship in Liverpool and Malawi and has ongoing collaborative work in range of global settings including Africa, Eastern Europe and South-East Asia. He is a member of the executive group of the EDCTP-funded Pan African Consortium for the Evaluation of Anti-Tuberculosis Antibiotics (PanACEA) and is part of the international Medical Monitoring Team for the ongoing TB Alliance sponsored SimpliciTB clinical trial.
Dr Sloan also has an interest in the acute management of infectious disease outbreaks. He was Quality Team Lead for the UK Emergency Medical Team (UK-EMT) response to the Ebola Virus Disease epidemic in West Africa in 2015, was Clinical Lead for the UK-EMT response to a diphtheria outbreak amongst the displaced Rohingya population on the Bangladesh-Myanmar border in 2018, and has undertaken two missions to strengthen Viral Haemorrhagic Fever preparedness in Rwanda.
This seminar will be live-streamed via: http://bit.ly/LSTM-Sem20-DS
A recording will be made available on the LSTM website the following day